Literature DB >> 28971280

Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR.

Lisa M Pastore1, Mindy S Christianson2, James Stelling3,4, William G Kearns2,5, James H Segars2.   

Abstract

There are large variations in the number of oocytes within each woman, and biologically, the total quantity is at its maximum before the woman is born. Scientific knowledge is limited about factors controlling the oocyte pool and how to measure it. Within fertility clinics, there is no uniform agreement on the diagnostic criteria for each common measure of ovarian reserve in women, and thus, studies often conflict. While declining oocyte quantity/quality is a normal physiologic occurrence as women age, some women experience diminished ovarian reserve (DOR) much earlier than usual and become prematurely infertile. Key clinical features of DOR are the presence of regular menstrual periods and abnormal-but-not-postmenopausal ovarian reserve test results. A common clinical challenge is counseling patients with conflicting ovarian reserve test results. The clinical diagnosis of DOR and the interpretation of ovarian reserve testing are complicated by changing lab testing options and processing for anti-mullerian hormone since 2010. Further, complicating the diagnostic and research scenario is the existence of other distinct yet related clinical terms, specifically premature ovarian failure, primary ovarian insufficiency, poor ovarian response, and functional ovarian reserve. The similarities and differences between the definitions of DOR with each of these four terms are reviewed. We recommend greater medical community involvement in terminology decisions, and the addition of DOR-specific medical subject-heading search terms.

Entities:  

Keywords:  Anti-mullerian hormone; Antral follicle count; Diminished ovarian reserve; Female infertility; Follicle-stimulating hormone; Ovarian reserve testing; Poor ovarian response; Premature ovarian failure; Primary ovarian insufficiency

Mesh:

Year:  2017        PMID: 28971280      PMCID: PMC5758472          DOI: 10.1007/s10815-017-1058-4

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  63 in total

Review 1.  Ovarian aging: mechanisms and clinical consequences.

Authors:  F J Broekmans; M R Soules; B C Fauser
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

Review 2.  The time is now for a new approach to primary ovarian insufficiency.

Authors:  Amber R Cooper; Valerie L Baker; Evelina W Sterling; Mary E Ryan; Teresa K Woodruff; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2010-02-26       Impact factor: 7.329

3.  Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.

Authors:  Siobán D Harlow; Margery Gass; Janet E Hall; Roger Lobo; Pauline Maki; Robert W Rebar; Sherry Sherman; Patrick M Sluss; Tobie J de Villiers
Journal:  Menopause       Date:  2012-04       Impact factor: 2.953

4.  Comparative evaluation of three new commercial immunoassays for anti-Müllerian hormone measurement.

Authors:  H W R Li; B P C Wong; W K Ip; W S B Yeung; P C Ho; E H Y Ng
Journal:  Hum Reprod       Date:  2016-10-04       Impact factor: 6.918

5.  Assessing the emotional needs of women with spontaneous premature ovarian failure.

Authors:  Allison A Groff; Sharon N Covington; Lynn R Halverson; O Ray Fitzgerald; Vien Vanderhoof; Karim Calis; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2005-06       Impact factor: 7.329

6.  Age-related normograms of serum antimüllerian hormone levels in a population of infertile women: a multicenter study.

Authors:  Benny Almog; Fady Shehata; Sami Suissa; Hananel Holzer; Einat Shalom-Paz; Antonio La Marca; Shanthi Muttukrishna; Andrew Blazar; Richard Hackett; Scott M Nelson; Joao Sabino Cunha-Filho; Talia Eldar-Geva; Ehud J Margalioth; Nick Raine-Fenning; Kannamannadiar Jayaprakasan; Myvanwy McIlveen; Dorothea Wunder; Thomas Freour; Luciano G Nardo; Juan Balasch; Joana Peñarrubia; Jesper Smeenk; Christian Gnoth; Erhard Godehardt; Tsung-Hsien Lee; Maw-Sheng Lee; Ishai Levin; Ronni Gamzu; Togas Tulandi
Journal:  Fertil Steril       Date:  2011-03-31       Impact factor: 7.329

7.  A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause.

Authors:  Karl R Hansen; Nicholas S Knowlton; Angela C Thyer; Jay S Charleston; Michael R Soules; Nancy A Klein
Journal:  Hum Reprod       Date:  2008-01-11       Impact factor: 6.918

Review 8.  Genetics of primary ovarian insufficiency: a review.

Authors:  Cristina Fortuño; Elena Labarta
Journal:  J Assist Reprod Genet       Date:  2014-09-18       Impact factor: 3.412

9.  National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys.

Authors:  Maya N Mascarenhas; Seth R Flaxman; Ties Boerma; Sheryl Vanderpoel; Gretchen A Stevens
Journal:  PLoS Med       Date:  2012-12-18       Impact factor: 11.069

10.  The importance of adrenal hypoandrogenism in infertile women with low functional ovarian reserve: a case study of associated adrenal insufficiency.

Authors:  Norbert Gleicher; Vitaly A Kushnir; Andrea Weghofer; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2016-04-26       Impact factor: 5.211

View more
  21 in total

Review 1.  Does theFMR1 gene affect IVF success?

Authors:  Lisa M Pastore; Mindy S Christianson; Bailey McGuinness; Kamaria Cayton Vaught; Jacqueline Y Maher; William G Kearns
Journal:  Reprod Biomed Online       Date:  2018-12-10       Impact factor: 3.828

2.  Diminished ovarian reserve in young women with sickle cell anemia.

Authors:  Lydia H Pecker; Sarah Hussain; Jaanvi Mahesh; Ravi Varadhan; Mindy S Christianson; Sophie Lanzkron
Journal:  Blood       Date:  2022-02-17       Impact factor: 22.113

3.  Investigation of the Predictive Factors of Diminished Ovarian Reserve in Women Aged Less Than 40 Years and Undergoing ICSI Cycle.

Authors:  Mohammed M Laqqan; Maged M Yassin
Journal:  Reprod Sci       Date:  2022-08-24       Impact factor: 2.924

4.  A Case-Control Study of Follicular Fluid Cytokine Profiles in Women with Diminished Ovarian Reserve.

Authors:  Ruo-Pan Huang; Anna K Knight; Sina Abhari; Jingqiao Lu; Heather S Hipp; Brianne Petritis; Sabrina A Gerkowicz; Quinton S Katler; Haw-Han Yen; Yingqing Mao; Hao Tang; Weirong Shang; Laurie J McKenzie; Alicia K Smith
Journal:  Reprod Sci       Date:  2021-11-04       Impact factor: 2.924

5.  Premature ovarian insufficiency patients with viable embryos derived from autologous oocytes through repeated oocyte retrievals could obtain reasonable cumulative pregnancy outcomes following frozen-embryo transfer.

Authors:  Xiuxian Zhu; Jing Ye; Yonglun Fu
Journal:  Ann Transl Med       Date:  2021-04

Review 6.  Mechanisms of ovarian aging.

Authors:  Selena U Park; Leann Walsh; Karen M Berkowitz
Journal:  Reproduction       Date:  2021-07-14       Impact factor: 3.923

7.  Association of birth weight with functional ovarian reserve during menacme estimated by serum concentration of anti-Müllerian hormone.

Authors:  Maria L S Lima; Gustavo S Romão; Heloisa Bettiol; Marco Antonio Barbieri; Rui A Ferriani; Paula A Navarro
Journal:  Sci Rep       Date:  2019-05-30       Impact factor: 4.379

Review 8.  Potential roles of experimental reproductive technologies in infertile women with diminished ovarian reserve.

Authors:  Zexu Jiao; Orhan Bukulmez
Journal:  J Assist Reprod Genet       Date:  2021-06-07       Impact factor: 3.357

9.  Reactivating Ovarian Function through Autologous Platelet-Rich Plasma Intraovarian Infusion: Pilot Data on Premature Ovarian Insufficiency, Perimenopausal, Menopausal, and Poor Responder Women.

Authors:  Konstantinos Sfakianoudis; Mara Simopoulou; Sokratis Grigoriadis; Agni Pantou; Petroula Tsioulou; Evangelos Maziotis; Anna Rapani; Polina Giannelou; Nikolaos Nitsos; Georgia Kokkali; Michael Koutsilieris; Konstantinos Pantos
Journal:  J Clin Med       Date:  2020-06-10       Impact factor: 4.241

10.  Comparison of modified agonist, mild-stimulation and antagonist protocols for in vitro fertilization in patients with diminished ovarian reserve.

Authors:  Rong Yu; Hao Jin; Xuefeng Huang; Jinju Lin; Peiyu Wang
Journal:  J Int Med Res       Date:  2018-04-25       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.